Anti-inflammatory effects of synthetic compound KT-14480 in lipopolysaccharide-stimulated microglia cells

Journal of Pharmacy and Pharmacology

Volumn 62, Issue 2, 2010, Pages 279-285

  Ock, Jiyeon ^a   Suk, Kyoungho ^a  

^a Kyungpook National University School of Medicine   (South Korea)

Author keywords

Fluorovinyloxyacetamides; Microglia; Neurodegenerative diseases; Neuroinflammation; Neuroprotection; Nitric oxide

Indexed keywords

ACETAMIDE DERIVATIVE; ANTIINFLAMMATORY AGENT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; KT 14480; KT 14482; KT 15069; KT 15070; KT 15071; KT 16513; KT 16547; KT 16581; KT 16582; LIPOPOLYSACCHARIDE; NITRIC OXIDE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; ACETANILIDE DERIVATIVE; LIPOPOLYSACCHARIDE, ESCHERICHIA COLI 0111 B4; MITOGEN ACTIVATED PROTEIN KINASE; NONSTEROID ANTIINFLAMMATORY AGENT;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; COCULTURE; CONTROLLED STUDY; DRUG INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION; IMMUNOCYTOCHEMISTRY; MICROGLIA; NEUROBLASTOMA; NEUROPROTECTION; NONHUMAN; PROTEIN EXPRESSION; PROTEIN SECRETION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING; ANIMAL; ANTAGONISTS AND INHIBITORS; BIOSYNTHESIS; CELL DEATH; CELL SURVIVAL; CHEMICAL STRUCTURE; DRUG EFFECTS; FLUORESCENT ANTIBODY TECHNIQUE; GENETICS; IMMUNOLOGY; METABOLISM; MOUSE; PATHOLOGY; TOXICITY; TUMOR CELL LINE;

ACETANILIDES; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BLOTTING, WESTERN; CELL DEATH; CELL LINE, TUMOR; CELL SURVIVAL; COCULTURE TECHNIQUES; ELECTROPHORETIC MOBILITY SHIFT ASSAY; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION; LIPOPOLYSACCHARIDES; MICE; MICROGLIA; MITOGEN-ACTIVATED PROTEIN KINASES; MOLECULAR STRUCTURE; NF-KAPPA B; NITRIC OXIDE; RATS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77949627096     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1211/jpp.62.02.0017     Document Type: Article

References (21)

1. Block ML et al. Microglia-mediated neurotoxicity: uncovering the molecular mechanisms. Nat Rev Neurosci 2007 8 : 57 69
2. McGeer PL et al. Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains. Neurology 1988 38 : 1285 1291
3. Blasi E et al. Immortalization of murine microglial cells by a v-raf/v-myc carrying retrovirus. J Neuroimmunol 1990 27 : 229 237
4. Bocchini V et al. An immortalized cell line expresses properties of activated microglial cells. J Neurosci Res 1992 31 : 616 621
5. Cheepsunthorn P et al. Characterization of a novel brain-derived microglial cell line isolated from neonatal rat brain. Glia 2001 35 : 53 62
6. Schubert D et al. Clonal cell lines from the rat central nervous system. Nature 1974 249 : 224 227
7. Ock J et al. Anti-inflammatory effects of a fluorovinyloxyacetamide compound KT-15087 in microglia cells. Pharmacol Res 2009 59 : 414 422
8. Zheng L et al. Suppressive effects of flavonoid fisetin on lipopolysaccharide-induced microglial activation and neurotoxicity. Int Immunopharmacol 2008 8 : 484 494
9. Schreiber E et al. Rapid detection of octamer binding proteins with 'mini-extracts', prepared from a small number of cells. Nucleic Acids Res 1989 17 : 6419
10. Walter S et al. Role of the toll-like receptor 4 in neuroinflammation in Alzheimer's disease. Cell Physiol Biochem 2007 20 : 947 956
11. Chang LC et al. Inhibition of nitric oxide production by the carbazole compound LCY-2-CHO via blockade of activator protein-1 and CCAAT/enhancer- binding protein activation in microglia. Biochem Pharmacol 2008 76 : 507 519
12. Meng XL et al. RV09, a novel resveratrol analogue, inhibits NO and TNF-alpha production by LPS-activated microglia. Int Immunopharmacol 2008 8 : 1074 1082
13. Baeuerle PA, Henkel T. Function and activation of NF-kappa B in the immune system. Annu Rev Immunol 1994 12 : 141 179
14. Mukaida N et al. Novel insight into molecular mechanism of endotoxin shock: biochemical analysis of LPS receptor signaling in a cell-free system targeting NF-kappaB and regulation of cytokine production/action through beta2 integrin in vivo. J Leukoc Biol 1996 59 : 145 151
15. Koistinaho M, Koistinaho J. Role of p38 and p44/42 mitogen-activated protein kinases in microglia. Glia 2002 40 : 175 183
16. Stoll G, Jander S. The role of microglia and macrophages in the pathophysiology of the CNS. Prog Neurobiol 1999 58 : 233 247
17. Streit WJ et al. Reactive microgliosis. Prog Neurobiol 1999 57 : 563 581
18. Meyer CF et al. Interaction between c-Rel and the mitogen-activated protein kinase kinase kinase 1 signaling cascade in mediating kappaB enhancer activation. J Biol Chem 1996 271 : 8971 8976
19. Stancovski I, Baltimore D. NF-kappaB activation: the I kappaB kinase revealed?. Cell 1997 91 : 299 302
20. Esposito E et al. Non-steroidal anti-inflammatory drugs in Parkinson's disease. Exp Neurol 2007 205 : 295 312
21. Zheng LT et al. The antipsychotic spiperone attenuates inflammatory response in cultured microglia via the reduction of proinflammatory cytokine expression and nitric oxide production. J Neurochem 2008 107 : 1225 1235